NEO

NEOGENOMICS INC

Services-Testing Laboratories · SIC 8734CIK 1077183Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$727.0M

Net Income FY2025

$(108.0M)

EPS (Basic, as reported)

—

Net Margin FY2025

-14.9%

ROE FY2025

-12.9%

Total Equity

$837.0M

Shares Out

128M

Business description

NEOGENOMICS INC — Services-Testing Laboratories. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2010–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 232 → 727 +13.5% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue232240277409444484510592661727

Cost of revenue(134)(138)(149)(212)(259)(297)(322)(347)(370)(413)

Gross profit110120127197186187188245290314

Research & development(5)(4)(3)(8)(8)(22)(30)(27)(31)(37)

Selling & marketing(24)(25)(29)(47)(48)(63)(67)(71)(85)(92)

General & administrative(76)(89)(85)(128)(144)(221)(243)(243)(260)(273)

Total operating expenses(108)(118)(117)(184)(200)(306)(346)(352)(382)(430)

Operating income321013(14)(119)(158)(108)(92)(116)

Interest expense(10)(6)(6)(4)(7)(5)(2)(7)(7)(4)

Interest & investment income—————3617189

Other income (expense), net000(5)1200100

Pre-tax income(7)(3)44(14)(15)(159)(97)(81)(110)

Income tax expense(2)(3)(1)(4)(18)(7)(15)(9)(2)(2)

Net income(6)(1)384(8)(144)(88)(79)(108)

EPS — basic——————————

EPS — diluted——————————

Shares outstanding — basic (M)787986100109120124126127128

Shares outstanding — diluted (M)787992104112120124126127128

Showing the latest 10 of 16 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.